Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Toxic“
Suchtreffer
Begriffe & Kennungen
Besponsa · 4.8 · Hepatotoxicity, including VOD/SOS
Eintrag öffnenBiopoin · 4.8 · Severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome (SJS) and toxic epidermal necrol
Eintrag öffnenBleivergiftung, Nervensystem
Eintrag öffnenBleivergiftung, Nervensystem, beim Erwachsenen
Eintrag öffnenBleivergiftung, Nervensystem, im Kindesalter
Eintrag öffnenBlitzima · 4.8 · In patients with non-Hodgkin’s lymphoma receiving rituximab in combination with cytotoxic chemotherapy, cases
Eintrag öffnenBlitzima · 4.8 · Skin and subcutaneous tissue disorders Toxic Epidermal Necrolysis (Lyell’s syndrome) and Stevens-Johnson syndr
Eintrag öffnenBortezomib Accord · 4.8 · 19 System Organ Class Incidence Adverse reaction Hepatobiliary Common Hepatotoxicity (inc liver disorder) diso
Eintrag öffnenBortezomib Accord · 4.8 · 20 Table 9: Incidence of peripheral neuropathy during induction treatment by toxicity and treatment discontinu
Eintrag öffnenBortezomib Accord · 4.8 · 52 System Organ Class Incidence Adverse reaction Hepatobiliary Common Hepatotoxicity (inc liver disorder) diso
Eintrag öffnenBortezomib Accord · 4.8 · 53 Table 9: Incidence of peripheral neuropathy during induction treatment by toxicity and treatment discontinu
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · 22 Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation du
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · 56 Table 9: Incidence of peripheral neuropathy during induction treatment by toxicity and treatment discontinu
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Table 9: Incidence of peripheral neuropathy during induction treatment by toxicity and treatment discontinuati
Eintrag öffnenBortezomib Sun · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Sun · 4.8 · Table 9: Incidence of peripheral neuropathy during induction treatment by toxicity and treatment discontinuati
Eintrag öffnenBosulif · 4.8 · At least 1 adverse reaction of any toxicity grade was reported for 1,349 (98.3%) patients. The most frequent a
Eintrag öffnen